Cite

HARVARD Citation

    Weiss, L. et al. (2020). Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy. Human molecular genetics. pp. 3945-3953. [Online]. 
  
Back to record